Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD63m

    Last close

    USD0.68

    ▲ 0.10 (16.35%)

    Creotech Instruments

    MCap

    PLN346m

    Last close

    PLN174.00

    ▲ 23.50 (15.61%)

    Creo Medical

    MCap

    GBP80m

    Last close

    GBP0.19

    ▲ 2.25 (13.24%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive Interview – EMIS Group

Executive Interview – EMIS Group

EMIS Group — 11 videos in collection

More on this equity

EMIS is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a dominant position with a market share of 55% of UK GP practices. It has expanded from this position to create a broad range of products serving the community, child and mental healthcare (CCMH) market, the acute sector, and community pharmacies (where it has c 37% share) as well specialist software and screening services for diabetic retinopathy. The company’ strategy is to provide connected healthcare solutions to facilitate patient-centric care.

< Previous
Next >

You may also be interested in these:

TMT

EMIS Group FY21 results – executive interview

TMT

EMIS Group – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free